100 related articles for article (PubMed ID: 4350031)
1. Mouse strain-related differences in the biologic and immunologic responses to a murine sarcoma virus.
Gazdar AF; Russell EK; Herberman RB
J Natl Cancer Inst; 1973 Apr; 50(4):971-8. PubMed ID: 4350031
[No Abstract] [Full Text] [Related]
2. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
Basombrio MA
Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
[No Abstract] [Full Text] [Related]
3. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
Plata F; Gomard E; Leclerc JC; Levy JP
J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
[No Abstract] [Full Text] [Related]
4. In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.
Lavrin DH; Herberman RB; Nunn M; Soares N
J Natl Cancer Inst; 1973 Nov; 51(5):1497-508. PubMed ID: 4762933
[No Abstract] [Full Text] [Related]
5. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
Burton RC; Warner NL
J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated antitumor immune reactions under syngeneic conditions.
Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
[No Abstract] [Full Text] [Related]
7. Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity.
Gorczynski RM; Knight RA
Br J Cancer; 1975 Apr; 31(4):387-404. PubMed ID: 50851
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated and humoral immunity studies of murine and hamster sarcoma virus-induced producer and non-producer tumors in syngeneic animals.
McCoy JL; Ting RC; McCoy NT; Reisher JI; Chan SP; Law LW
Int J Cancer; 1974 May; 13(5):731-41. PubMed ID: 4367343
[No Abstract] [Full Text] [Related]
9. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
Weiland E; Weiland F
Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
[No Abstract] [Full Text] [Related]
10. An anemia-inducing virus derived from tumors caused by murine sarcoma virus--Moloney.
Taylor DO; Cremer NE; Oshiro LS; Lennette EH
J Natl Cancer Inst; 1972 Sep; 49(3):829-45. PubMed ID: 4345969
[No Abstract] [Full Text] [Related]
11. Stimulation of tumor cell growth in vitro: a critical evaluation of immunologic specificity.
Lamon EW
J Natl Cancer Inst; 1977 Sep; 59(3):769-74. PubMed ID: 70536
[No Abstract] [Full Text] [Related]
12. Breakdown of Gross virus-induced tolerance in rats by inoculation of lymphoid cells.
Takeichi N; Kuzumaki N; Kodama T; Kobayashi H
J Natl Cancer Inst; 1974 Jun; 52(6):1817-22. PubMed ID: 4834410
[No Abstract] [Full Text] [Related]
13. Cellular immunity in mice with simian virus 40-induced mKSA tumors: comparison of three assays of tumor immunity.
Howell SB; Esber EC; Law LW
J Natl Cancer Inst; 1974 Apr; 52(4):1361-3. PubMed ID: 4363713
[No Abstract] [Full Text] [Related]
14. The humoral antibody response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice.
Lamon EW; Klein E; Andersson B; Fenyö EM; Skurzak HM
Int J Cancer; 1973 Nov; 12(3):637-45. PubMed ID: 4364795
[No Abstract] [Full Text] [Related]
15. Immune response to polyoma tumor cells in mice. I. Magnitude and specificity of the in vitro cellular cytotoxicity elicited by immunization with graded numbers of tumor cells.
Walia AS; Lamon EW
J Natl Cancer Inst; 1977 Jun; 58(6):1671-5. PubMed ID: 194042
[No Abstract] [Full Text] [Related]
16. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
Basombrío MA; Mayer AM; Pasqualini CD
Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice.
Bekesi JG; Roboz JP; Holland JF
Isr J Med Sci; 1976; 12(4-5):288-303. PubMed ID: 181351
[TBL] [Abstract][Full Text] [Related]
18. Immune response to rauscher virus-induced leukemia in DBA mice. I. Role of cellular and humoral immunity in spontaneous regression.
Tóth FD; Gomba S; Váczi L; Kása M; Jakó J
Neoplasma; 1976; 23(5):471-81. PubMed ID: 980178
[TBL] [Abstract][Full Text] [Related]
19. Properties of a murine sarcoma virus isolated from a tumor arising in an NZW-NZB F 1 hybrid mouse. I. Isolation and pathology of tumors induced in rodents.
Gazdar AF; Chopra HC; Sarma PS
Int J Cancer; 1972 Jan; 9(1):219-33. PubMed ID: 4335642
[No Abstract] [Full Text] [Related]
20. Assessment of reactivities of natural antibodies to endogenous RNA tumor virus envelope antigens and virus-induced cell surface antigens.
Hanna MG; Ihle JN; Batzing BL; Tennant TW; Schenley CK
Cancer Res; 1975 Jan; 35(1):164-71. PubMed ID: 45890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
